Last reviewed · How we verify

NCT05951985: SHIFT-AR

High Intensity Functional Training for Individuals With Neurologic Diagnoses and Their Care Partners

Completed NA Last updated 22 August 2025
What this trial tests

NA trial testing HIFT in Neurologic Disorder in 100 participants. Completed in 14 August 2025.

Timeline
15 August 2023
Primary endpoint
14 July 2025
14 August 2025

Quick facts

Lead sponsorArkansas Colleges of Health Education
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment100
Start date15 August 2023
Primary completion14 July 2025
Estimated completion14 August 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Arkansas Colleges of Health Education

Who can join

18 and older, any sex, with Neurologic Disorder or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Individuals with and without neurologic diagnoses greatly benefit from participation in regular exercise but the majority are physically inactive. This is an issue for both them and their care partners as their health is often linked. This study aims to examine the long-term physical and psychosocial effects of structured, group-based, high intensity functional training (HIFT) exercise for people with neurologic diagnoses and their care partners.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neurologic Disorder

Currently open trials in the same condition.

Other Arkansas Colleges of Health Education trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05951985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing